Beactica AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Beactica AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10875
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Beactica AB (Beactica) is a drug discovery company develops a pipeline of novel and mechanistically defined small molecule therapeutics. The company offers wide range of services such as fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis and antibody interaction analysis, discovery of non-competitive ligands and allosteric sites among others. It uses SPR-based small molecule drug discovery platform for lead identification and optimization. The company works in strategic collaborations with pharmaceutical companies to develop small molecule therapeutics. Beactica is headquartered in Uppsala, Sweden.

Beactica AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Beactica AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Beactica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Beactica AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Beactica AB, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Beactica Raises Funds Through Venture Financing 10
Beactica Raises Funds through Venture Financing 11
Partnerships 12
Beactica Enters into Research Agreement with Uppsala University and SciLifeLab 12
Beactica Enters into Drug Discovery Agreement with Medivir 13
Beactica Expands Drug Discovery Agreement With Boehringer Ingelheim 14
Beactica Enters Into Research Agreement With Janssen Research & Development 15
Licensing Agreements 16
Dong-A ST Enters into Licensing Agreement with Beactica 16
Beactica AB – Key Competitors 17
Beactica AB – Key Employees 18
Beactica AB – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Nov 06, 2017: Beactica Appoints Erik Wallden and Uli Hacksell to its Board of Directors 20
Government and Public Interest 21
Apr 18, 2018: Beactica wins European Horizon 2020 innovation grant for project targeting aggressive brain tumours 21
Nov 22, 2017: Beactica awarded funding to develop new therapeutics against aggressive brain tumours 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Beactica AB, Pharmaceuticals & Healthcare, Key Facts 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Beactica AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Beactica AB, Deals By Therapy Area, 2012 to YTD 2018 8
Beactica AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Beactica Raises Funds Through Venture Financing 10
Beactica Raises Funds through Venture Financing 11
Beactica Enters into Research Agreement with Uppsala University and SciLifeLab 12
Beactica Enters into Drug Discovery Agreement with Medivir 13
Beactica Expands Drug Discovery Agreement With Boehringer Ingelheim 14
Beactica Enters Into Research Agreement With Janssen Research & Development 15
Dong-A ST Enters into Licensing Agreement with Beactica 16
Beactica AB, Key Competitors 17
Beactica AB, Key Employees 18
Beactica AB, Other Locations 19

List of Figures
Beactica AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Beactica AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Beactica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Beactica AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sorrento Therapeutics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sorrento Therapeutics, Inc. Mer …
  • Bannerman Resources Limited (BNNLF):企業の財務及び戦略的SWOT分析
    Summary Bannerman Resources Limited (Bannerman) is an energy company that offers exploration services. The company offers uranium exploration and development services. It carries out acquisition, exploration and development of uranium projects. Bannerman has interest in the Etango Uranium Project lo …
  • ProQR Therapeutics NV (PRQR):企業の財務・戦略的SWOT分析
    Summary ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders. The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide …
  • Kosmos Energy, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Kosmos Energy, Ltd. Mergers and …
  • Boston-Power, Inc.:企業のM&A・提携動向(発電分野)
    Summary Boston-Power, Inc. (Boston-Power) is a developer and manufacturer of lithium-ion battery and pack technologies. The company provides rechargeable lithium-ion cells under two brands, namely, Sonata and Swing. Its Sonata product range finds application in portable power and notebook computer m …
  • P&F Industries, Inc. (PFIN):企業財務及び戦略的SWOT分析
    Summary P&F Industries, Inc. (P&F Industries) is an industrial equipment company that offers hardware products and tools. The company develops, imports, and manufactures fencing hardware, patio products, and door and window accessories which include rollers, hinges, window operators, sash locks, cus …
  • Cracker Barrel Old Country Store, Inc.:企業の戦略・SWOT・財務分析
    SummaryCracker Barrel Old Country Store, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of t …
  • RKJ Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' RKJ Group Mergers and Acquisiti …
  • Datawatch Corporation (DWCH):企業概要、財務及び戦略的SWOT分析
    Summary Datawatch Corporation (Datawatch) is a software development company. The company offers products such as datawatch desktop, datawatch server and datawatch report mining server. Its datawatch desktop include visual data discovery, data visualizations, analysis of real-time streams, time serie …
  • Hoverink Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Hoverink Biotechnologies Inc (Hoverink) formerly Hoverink International Holdings Inc, is a preclinical biopharmaceutical company that discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and on …
  • Dalian Port (PDA) Company Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Dalian Port (PDA) Company Limit …
  • LHC Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' LHC Group, Inc. Mergers and Acq …
  • Alibaba.com Limitedの企業概要及び財務/SWOT分析
    Alibaba.com Limited Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly f …
  • Kyowa Hakko Kirin Co., Ltd.:企業のM&A・提携・投資分析
    Kyowa Hakko Kirin Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kyowa Hakko Kirin Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Northwest Territories Power Corp:企業の戦略的SWOT分析
    Northwest Territories Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Akka Technologies SA (AKA):企業概要、財務及び戦略的SWOT分析
    Summary Akka Technologies SA (Akka) is a technology consulting and engineering company. The company offers a range of technological and engineering services. It provides services such as systems engineering, mechanical engineering, process engineering, technical documentation, embedded software and …
  • GE Capital (Thailand) Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' GE Capital (Thailand) Limited M …
  • SCANA Corporation:企業の戦略・SWOT・財務分析
    SummarySCANA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Guangxi Guiguan Electric Power Co., Ltd. (600236):企業のM&A・提携動向(エネルギー分野)
    Summary Guangxi Guiguan Electric Power Co., Ltd. (GGEP) a subsidiary of China Datang Corporation is an energy company that operates power stations. The company constructs, develops and operates power station for electricity generation. It constructs and operates hydro power stations, thermoelectric …
  • Sirius International Insurance Corporation:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Sirius International Insurance Corporation" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆